White paper

Non-clinical aspects of RNA-based drug development

Non-clinical aspects of RNA-based drug development

Author: Dr Anika Schröter


Classification of drugs, impact on non-clinical program, class-specific considerations

The development of RNA-based drugs has increased within the past years and is a promising field of research in the pharmaceutical industry. It is transforming the industry and will offer new hope for patients with unmet medical needs.

RNA-based drugs have several advantages over conventional drugs, such as the ability to target previously undruggable pathways, the rapid and cost-effective development, and the potential for personalized medicine. However, RNA-based drugs also face some challenges, such as the stability, delivery, and safety of the RNA molecules.

This whitepaper informs about the challenges with the 'standard' non-clinical program for different RNA-based drugs, focusing on safety evaluation.

Download now the white paper 'Non-clinical aspects of RNA-based drug development'.

We hope you enjoy reading it!


White paper

Non-clinical aspects of RNA-based drug development



I agree that the FORUM Institut may contact me to inform me about events and relevant content.
I can revoke my permission at any time.
6 + 11 =   

Events “

Do filter
Global Regulatory Affairs Manager

With this qualification course, you can continue your education in a structured manner in all global regulatory affairs topics, with a regional or country-specific focus.

Prior Use before The UPC, The EPO, German, Chinese And U.S. Courts

Gain strategic insights into utilizing prior use rights across multiple jurisdictions in this practical course. Learn to assert defense rights effectively before the UPC, EPO, and national courts in Germany, China, and the US, through the analysis of diverse case studies.

online 14/03/2024
IT validation in GxP

Are you looking for comprehensive expertise to prepare your company's IT for external controls in a compliance-compliant manner with regard to validation processes? On the other hand, do you want to organise the corresponding workflows as efficiently as possible? Get the tools you need to successfully implement your validation projects in our seminar!

online 22-23/04/2024
Managing the Recovery and Resilience Funds

The EU's Recovery and Resilience Facility (RRF) is an essential part of the EU's economic recovery plan, providing grants and loans to member states. Since its launch in 2021, implementation has been uneven across EU countries. What are the reasons for these differences in implementation between EU countries, and how can one navigate the new system for successful RRF funding?

Heidelberg 16-17/05/2024
IP Protection for Plant Innovation 2024

The conference offers you once again the most recent developments in IP for the seed industry and the breeders.

Amsterdam, optional Online 13-14/06/2024
Marketing Authorisation in Latin America

An online seminar to discuss real cases/challenges for marketing authorisation in Mexico, Argentina, Colombia, Peru, Chile and Brazil with local experts from Brazil and Spain.

online 26-27/09/2024
PharmaFORUM Webcast International

Our global and local experts will update you every two months with the latest regulatory and legislative developments. Thus, you will always have the essential information and trends in regulatory affairs at your fingertips!

PharmaFORUM Webcast Biologics 2024

Our biotech experts will provide you with the latest information on issues related to development, quality and regulatory affairs of biologics every month in a two-hour webcast, in particular with regard to CMC.